Sacrococcygeal disorders, not elsewhere classified

M13_SACROCOGG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M53.3 Hospital discharge: ICD-9 — 7246 Cause of death: ICD-10 — M53.3 Cause of death: ICD-9 — 7246 2 out of 7 registries used, show all original rules.	1223
4. Check minimum number of events None	1223
5. Include endpoints None	1223
6. Filter based on genotype QC (FinnGen only)	1223

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M53
Name in latin: Morbositates sacrococcygeales, non alibi classificatae

NAME	M13_SACROCOGG
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M533
HD_ICD_9	7246
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M533
COD_ICD_9	7246
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sacrococcygeal disorders, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7581	5556	1989
Only index persons	7232	5346	1886
Unadjusted period prevalence (%)
Whole population	0.13	0.16	0.06
Only index persons	0.16	0.20	0.07
Median age at first event (years)
Whole population	47.81	47.55	48.65
Only index persons	47.31	47.12	47.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1223	980	243
Unadjusted period prevalence (%)	0.29	0.33	0.11
Median age at first event (years)	47.63	46.41	52.56

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1107: Matched controls
11070

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

10523.1

323.0

1064

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

66.2

271.1

311

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

68.1

246.0

281

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

77.9

230.6

258

M54.5

ICD-10 Finland

Low back pain

7.1

180.7

577

1469

N03AX16

ATC

pregabalin; oral

8.0

165.3

444

857

M54.4

ICD-10 Finland

Lumbago with sciatica

9.8

140.9

313

428

M48.0

ICD-10 Finland

Spinal stenosis

54.0

135.9

162

N03AX12

ATC

gabapentin; oral

9.1

131.1

305

446

N02AX02

ATC

tramadol; systemic, rectal

4.5

114.5

594

2277

M54.9

ICD-10 Finland

Dorsalgia, unspecified

9.7

101.1

219

273

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

94.6

93.8

103

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

62.1

92.0

107

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

9.0

91.3

207

276

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

13.0

89.2

164

146

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

444.9

84.2

M03BC01

ATC

orphenadrine (citrate); systemic

3.9

76.6

397

1387

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

19.6

76.5

118

N06AX21

ATC

duloxetine; oral

6.3

75.7

221

421

M79.6

ICD-10 Finland

Pain in limb

3.4

75.4

517

2259

M03BX02

ATC

tizanidine; oral

3.4

74.7

821

5053

N06AA09

ATC

amitriptyline; systemic

6.5

71.0

201

366

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

93.2

70.9

M01AH05

ATC

etoricoxib; oral

3.2

68.7

776

4711

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.0

66.1

604

3139

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.1

65.7

521

2457

M54.3

ICD-10 Finland

Sciatica

14.7

64.6

111

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

105.0

63.6

M25.5

ICD-10 Finland

Pain in joint

3.2

62.5

435

1854

A02BC02

ATC

pantoprazole; systemic

3.0

60.7

785

4994

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

35.9

57.5

L03

ICPC

Low back symptom/complaint

3.5

56.8

326

1187

A02BC05

ATC

esomeprazole; systemic

2.8

56.2

546

2844

M01AB05

ATC

diclofenac; systemic, rectal

2.9

56.2

821

5489

NEK10

NOMESCO Finland

Excision of fragment of bone of pelvis

+∞

55.7

M47.82

ICD-10 Finland

Other spondylosis, cervical region

37.3

54.8

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

54.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.0

50.5

368

1568

M53.1

ICD-10 Finland

Cervicobrachial syndrome

4.9

50.0

177

411

M01AH01

ATC

celecoxib; oral (coxibs)

3.5

48.7

266

917

M70.6

ICD-10 Finland

Trochanteric bursitis

4.2

48.5

203

557

M54.6

ICD-10 Finland

Pain in thoracic spine

7.2

47.4

120

183

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.0

46.7

346

1477

N06AX16

ATC

venlafaxine; oral

3.6

46.2

240

792

M54.1

ICD-10 Finland

Radiculopathy

18.0

45.2

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

45.2

455

2333

7246A

ICD-9 Finland

Other and unspecified disorders of back, Disorders of sacrum

+∞

45.1

UJF32

NOMESCO Finland

Coloscopy

2.9

44.6

327

1378

G44.2

ICD-10 Finland

Tension-type headache

3.6

43.7

226

741

M43.1

ICD-10 Finland

Spondylolisthesis

33.3

43.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

43.5

352

1578

M54.8

ICD-10 Finland

Other dorsalgia

9.9

43.1

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

24.8

41.8

M35.7

ICD-10 Finland

Hypermobility syndrome

24.8

41.8

H02AB06

ATC

prednisolone; systemic

2.4

41.1

549

3224

A02BA02

ATC

ranitidine; systemic

3.1

40.9

262

1001

N02BE01

ATC

paracetamol; systemic, rectal

3.1

40.5

978

7827

A02BC03

ATC

lansoprazole; oral

2.6

39.8

360

1708

SPAT1212

SPAT

Extensive examination of musculoskeletal system

4.7

39.7

145

344

M03BC51

ATC

orphenadrine, combinations; systemic

2.6

39.6

385

1898

M54.2

ICD-10 Finland

Cervicalgia

6.5

39.4

107

179

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

39.3

457

2481

RF210

NOMESCO Finland

8.7

39.3

107

J02AC01

ATC

fluconazole; systemic

2.3

39.2

595

3688

M47.9

ICD-10 Finland

Spondylosis, unspecified

141.7

39.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

38.7

294

1253

R51.80

ICD-10 Finland

Headache

3.3

38.5

222

784

M53.0

ICD-10 Finland

Cervicocranial syndrome

4.4

36.4

140

349

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

36.0

323

1510

A02BC01

ATC

omeprazole; systemic

2.6

35.9

331

1568

M01AC06

ATC

meloxicam; systemic, rectal

2.3

35.8

448

2493

R10.2

ICD-10 Finland

Pelvic and perineal pain

10.8

35.7

R01AD09

ATC

mometasone; nasal

2.2

35.4

585

3706

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.6

35.2

314

1457

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.4

35.1

100

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.8

35.0

160

468

M01AE02

ATC

naproxen; oral, rectal

2.2

35.0

674

4572

M01AX17

ATC

nimesulide; oral

2.6

34.3

295

1338

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

33.5

M02AA07

ATC

piroxicam; topical

2.3

33.5

434

2434

M01AB55

ATC

diclofenac, combinations; oral

5.0

33.2

112

243

Z01.8

ICD-10 Finland

Other specified special examinations

2.7

33.2

270

1185

J01AA02

ATC

doxycycline; systemic

2.5

33.1

903

7108

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

26.0

32.5

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

32.4

R03AC02

ATC

salbutamol; inhalant

2.1

32.3

626

4188

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

32.3

202

748

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.9

31.8

222

883

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

13.4

31.4

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

31.2

293

1386

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

72.0

31.0

M45

ICD-10 Finland

Ankylosing spondylitis

72.0

31.0

M79.7

ICD-10 Finland

Fibromyalgia

7.5

30.8

104

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

10.2

30.4

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

109.7

29.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

29.5

442

2610

RF223

NOMESCO Finland

106.2

28.8

R06.0

ICD-10 Finland

Dyspnoea

2.5

28.2

273

1302

M01AH02

ATC

rofecoxib; oral

3.2

28.1

164

575

J01FA06

ATC

roxithromycin; oral

2.1

28.1

492

3082

WX002

NOMESCO Finland

Sedation and analgesia

2.5

27.7

246

1120

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.8

27.6

110

N06AX11

ATC

mirtazapine; oral

2.2

27.5

372

2084

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

27.2

220

950

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

27.2

534

3494

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

27.1

317

1656

R2110

NOMESCO Finland

Giving the first information

3.4

26.9

138

440

M50.3

ICD-10 Finland

Other cervical disc degeneration

26.5

26.3

P01AB01

ATC

metronidazole; oral, rectal

2.0

26.1

500

3221

R4110

NOMESCO Finland

Physiotherapy

2.2

26.0

312

1648

RF421

NOMESCO Finland

33.9

25.7

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

17.2

25.5

N05CF01

ATC

zopiclone; oral

2.1

25.1

353

1993

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

15.2

24.9

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

24.7

216

969

R52.2

ICD-10 Finland

Other chronic pain

7.5

24.3

R42

ICD-10 Finland

Dizziness and giddiness

2.4

24.2

237

1128

M54

ICD-10 Finland

Dorsalgia

3.1

24.2

143

505

ZXA05

NOMESCO Finland

Left side

2.3

23.9

270

1379

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

88.7

23.7

R03DC03

ATC

montelukast; oral

2.5

23.6

217

999

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

23.6

812

6411

M79.1

ICD-10 Finland

Myalgia

2.8

23.6

162

629

A03FA02

ATC

cisapride; oral, rectal

3.8

23.4

104

294

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

66.4

22.9

RF120

NOMESCO Finland

18.0

22.7

L86

ICPC

Back syndrome with radiating pain

5.5

22.6

130

R4120

NOMESCO Finland

Occupational therapy

3.9

22.5

267

N03AE01

ATC

clonazepam; systemic

4.4

22.3

199

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

22.2

182

784

J01DA01

ATC

[U] cefalexin; systemic

1.9

22.1

704

5331

XF600

NOMESCO Finland

Bloodpressure measurement

3.9

22.0

262

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

22.0

396

2447

NAK99

NOMESCO Finland

Other operation on vertebra, unspecified

+∞

21.9

M76.3

ICD-10 Finland

Iliotibial band syndrome

29.7

21.9

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.3

21.8

115

373

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

224.2

21.7

S33.6

ICD-10 Finland

Sprain and strain of sacroiliac joint

117.3

21.6

M35.3

ICD-10 Finland

Polymyalgia rheumatica

5.8

21.6

112

N05BA01

ATC

diazepam; systemic, rectal

2.7

21.5

162

665

L01

ICPC

Neck symptom/complaint

2.7

21.2

162

668

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

4.0

21.1

235

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.1

21.1

311

1768

G54.0

ICD-10 Finland

Brachial plexus disorders

8.8

21.0

RF232

NOMESCO Finland

213.8

20.6

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

30.7

20.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

20.6

437

2849

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.7

20.5

273

R01BA52

ATC

pseudoephedrine, combinations; oral

1.9

20.4

386

2413

WX110

NOMESCO Finland

Local anesthesy

1.9

20.3

778

6176

J01DB01

ATC

cefalexin; oral

2.0

20.3

898

7515

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

20.1

176

785

N02AA05

ATC

oxycodone; systemic

2.9

20.1

135

514

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

20.1

441

2903

WX308

NOMESCO Finland

Sacral anesthesy

+∞

19.8

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

106.9

19.6

M53.2

ICD-10 Finland

Spinal instabilities

106.9

19.6

S32.2

ICD-10 Finland

Fracture of coccyx

14.1

19.6

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.1

19.3

111

383

R01AD08

ATC

fluticasone; nasal

1.9

19.3

345

2102

R20.2

ICD-10 Finland

Paraesthesia of skin

3.5

19.0

279

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

18.9

148

617

9211

FHL

Exploration or removal of diskusprolapse

+∞

18.8

RF310

NOMESCO Finland

28.4

18.8

A02BA04

ATC

nizatidine; systemic

3.3

18.8

310

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

18.7

222

1143

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

18.6

102

340

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

39.1

18.6

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

18.6

728

5725

UKC02

NOMESCO Finland

Cystoscopy

2.6

18.5

141

582

SPAT1153

SPAT

Removal of sutures

1.9

18.4

317

1899

G47.3

ICD-10 Finland

Sleep apnoea

2.2

18.4

218

1122

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

18.3

201

999

ZXA10

NOMESCO Finland

Bilateral

2.2

18.2

205

1030

J01FA10

ATC

azithromycin; systemic

1.8

18.2

668

5131

C07AB07

ATC

bisoprolol; oral

1.8

18.0

421

2799

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.8

18.0

XKD00

NOMESCO Finland

Uroflowmetry

2.9

17.9

112

408

J01MA02

ATC

ciprofloxacin; systemic

1.8

17.9

393

2560

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

8.1

17.9

R53

ICD-10 Finland

Malaise and fatigue

2.1

17.8

220

1149

L08

ICPC

Shoulder symptom/complaint

2.2

17.8

202

1018

R06AE07

ATC

cetirizine; oral

1.8

17.8

509

3608

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.7

17.8

R51.81

ICD-10 Finland

Facial pain NOS

6.5

17.8

J01FA09

ATC

clarithromycin; systemic

1.8

17.8

368

2347

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.3

17.7

295

AA1AD

NOMESCO Finland

CT of head and brain

2.1

17.7

219

1145

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

96.6

17.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

17.6

335

2074

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.5

17.6

149

650

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

17.6

619

4671

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.7

17.5

644

4920

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

17.5

436

2955

KMAK

NOMESCO Finland

1.7

17.5

603

4517

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

17.3

17.4

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.4

17.4

266

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.1

17.4

333

N06AA10

ATC

nortriptyline; systemic

8.7

17.3

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.5

17.1

141

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.2

17.1

303

K59.4

ICD-10 Finland

Anal spasm

32.0

17.1

R52.9

ICD-10 Finland

Pain, unspecified

3.0

17.1

101

353

ZXA00

NOMESCO Finland

Right side

2.0

17.0

273

1584

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

17.0

140

601

M01AE01

ATC

ibuprofen; systemic, rectal

2.3

16.9

1001

8923

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

16.7

167

792

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

16.7

RF124

NOMESCO Finland

+∞

16.7

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

+∞

16.7

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

16.7

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

16.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

16.7

180

886

C07AA05

ATC

propranolol; systemic

2.0

16.7

234

1287

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

16.6

113

435

A01AB09

ATC

miconazole; local oral

2.8

16.6

109

411

M41.9

ICD-10 Finland

Scoliosis, unspecified

28.0

16.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.4

16.5

249

L02

ICPC

Back symptom/complaint

2.8

16.5

109

412

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.2

16.5

193

984

G43.9

ICD-10 Finland

Migraine, unspecified

3.2

16.5

294

R03BA01

ATC

beclometasone; inhalant

2.3

16.4

165

785

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.5

16.3

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

16.3

543

3992

Z71.8

ICD-10 Finland

Other specified counselling

1.9

16.3

269

1576

N06AB04

ATC

citalopram; systemic

2.0

16.2

247

1403

TAC99

NOMESCO Finland

Other blockade for chronic pain

15.6

16.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.7

16.2

497

3565

R06AX27

ATC

desloratadine; oral

1.8

16.1

329

2076

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

16.0

266

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

9.7

16.0

SPAT1301

SPAT

No procedures

1.8

15.9

317

1983

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

15.8

591

4476

A02BC04

ATC

rabeprazole; oral

2.8

15.8

107

408

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

15.7

124

521

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

86.3

15.6

N05BA04

ATC

oxazepam; oral

1.9

15.4

269

1603

N06AB10

ATC

escitalopram; oral

2.0

15.4

242

1388

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

15.3

327

2088

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.1

15.3

197

1045

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

15.3

145

668

K30

ICD-10 Finland

Functional dyspepsia

2.5

15.2

126

540

K02.1

ICD-10 Finland

Caries of dentine

1.7

15.2

623

4816

M43.0

ICD-10 Finland

Spondylolysis

45.6

15.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

15.0

262

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.4

14.9

135

607

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

14.8

329

J31.0

ICD-10 Finland

Chronic rhinitis

2.8

14.7

101

389

R07.3

ICD-10 Finland

Other chest pain

2.7

14.7

102

397

NA5AA

NOMESCO Finland

Coccyx X-ray examination

+∞

14.6

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

81.2

14.6

A07EC01

ATC

sulfasalazine; oral, rectal

2.9

14.5

338

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

14.5

167

843

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.3

14.4

135

619

N05CF02

ATC

zolpidem; oral

2.0

14.4

203

1113

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

14.3

172

885

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

13.6

14.2

00000

ICD-8 Finland

7.8

14.2

H02AB04

ATC

methylprednisolone; systemic

2.1

14.2

163

823

SPAT1240

SPAT

Therapeutic discussion

2.3

13.9

132

610

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

13.9

306

1961

Z01.2

ICD-10 Finland

Dental examination

1.7

13.9

459

3317

J01EA01

ATC

trimethoprim; systemic

1.8

13.7

290

1835

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

13.7

103

421

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.6

13.6

103

423

L28

ICPC

Limited function/disability (L)

2.3

13.6

132

616

NAK10

NOMESCO Finland

Excision of fragment of vertebra, unspecified

+∞

13.6

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

13.6

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

+∞

13.6

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.7

13.6

102

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

13.5

315

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.7

13.4

375

N04BC05

ATC

pramipexole; oral

3.0

13.4

272

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.7

13.4

350

M01AB08

ATC

etodolac; oral

2.8

13.4

326

M53.8

ICD-10 Finland

Other specified dorsopathies

21.4

13.4

R5140

NOMESCO Finland

Monitoring the use of the aid

2.5

13.3

106

444

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.2

13.3

233

RF220

NOMESCO Finland

6.5

13.3

L13

ICPC

Hip symptom/complaint

2.2

13.3

150

749

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

13.2

190

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

4.3

13.2

119

M01AE52

ATC

naproxen and esomeprazole; oral

4.3

13.2

119

M01AG02

ATC

tolfenamic acid; oral, rectal

1.9

13.1

208

1192

M01AX05

ATC

glucosamine; oral

2.0

13.1

181

985

SPAT1260

SPAT

Consultation of another employee

2.0

13.0

182

990

TAB20

NOMESCO Finland

Epidural puncture

16.9

13.0

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

6.0

12.9

C05AA08

ATC

fluocortolone; rectal, topical

2.1

12.7

161

843

N06AX03

ATC

mianserin; oral

3.6

12.7

169

M01AC01

ATC

piroxicam; systemic, rectal

2.2

12.7

133

639

S18

ICPC

Laceration/cut

1.7

12.7

386

2706

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

12.7

105

450

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.3

12.7

208

K08.80

ICD-10 Finland

Toothache NOS

2.4

12.7

113

504

N05AH04

ATC

quetiapine; oral

2.0

12.6

168

898

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.1

12.6

231

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

12.6

269

1702

RF230

NOMESCO Finland

32.4

12.6

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

11.2

12.6

J34.2

ICD-10 Finland

Deviated nasal septum

3.4

12.5

182

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

12.5

104

446

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.1

12.5

242

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

12.5

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

12.5

242

1480

M53.9

ICD-10 Finland

Dorsopathy, unspecified

20.3

12.5

Z50.1

ICD-10 Finland

Other physical therapy

3.4

12.5

183

RF123

NOMESCO Finland

131.4

12.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

12.4

104

450

SPAT1229

SPAT

Assessment of need for aid

2.9

12.4

274

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

12.3

505

3817

H02AB07

ATC

prednisone; oral

2.1

12.3

154

802

N03AF01

ATC

carbamazepine; oral, rectal

3.5

12.3

174

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.7

12.3

325

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

12.2

240

1476

R00.2

ICD-10 Finland

Palpitations

2.6

12.2

351

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

12.2

238

1462

L17

ICPC

Foot/toe symptom/complaint

1.8

12.1

234

1430

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.7

12.1

314

R03BA02

ATC

budesonide; inhalant

1.9

12.1

193

1106

M22.4

ICD-10 Finland

Chondromalacia patellae

4.0

12.1

120

J01FF01

ATC

clindamycin; systemic

1.7

12.0

277

1787

SPAT1216

SPAT

Assessment of functional ability

2.2

12.0

130

635

X58

ICD-10 Finland

Exposure to other specified factors

2.1

11.9

136

680

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

11.9

193

1111

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

11.9

546

4238

L29

ICPC

Musculoskeletal sympt/complt other

2.7

11.9

312

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.9

11.9

127

M77.1

ICD-10 Finland

Lateral epicondylitis

2.5

11.8

394

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.1

11.8

136

683

N03AX09

ATC

lamotrigine; oral

3.1

11.8

208

K07.60

ICD-10 Finland

Snapping jaw

2.9

11.8

266

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.6

11.7

341

M02AA10

ATC

ketoprofen; topical

2.0

11.7

165

902

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.2

11.7

124

602

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

19.2

11.6

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

11.6

160

865

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

11.5

130

649

R05FB02

ATC

cough suppressants and expectorants

1.6

11.4

394

2836

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

121.2

11.4

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.4

11.4

163

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.5

11.4

364

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

11.3

412

DHB50

NOMESCO Finland

Turbinoplasty

4.1

11.3

108

F32.1

ICD-10 Finland

Moderate depressive episode

2.9

11.2

250

K59.09

ICD-10 Finland

Constipation, unspecified

3.3

11.2

177

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

25.3

11.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.2

11.1

194

K59.0

ICD-10 Finland

Constipation

3.2

11.1

189

SPAT1263

SPAT

Sampling

1.6

11.1

411

3010

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

11.0

225

1395

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.8

11.0

253

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

11.0

284

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

11.0

413

3031

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

11.0

202

WZA90

NOMESCO Finland

Other doctors statement

1.8

11.0

229

1431

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

43.8

10.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

10.9

213

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

10.8

111

529

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.3

10.8

165

M01AX01

ATC

nabumetone; oral

3.3

10.8

165

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

28.3

10.7

G04CA02

ATC

tamsulosin; oral

2.2

10.7

108

512

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.8

10.7

119

R06AX13

ATC

loratadine; oral

1.9

10.6

176

1016

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.2

10.6

N02AC04

ATC

dextropropoxyphene; oral

4.5

10.5

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

10.5

357

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

+∞

10.4

A01

ICPC

Pain general/multiple sites

2.7

10.4

279

M01AB01

ATC

indometacin; systemic, rectal

2.9

10.4

231

M76.6

ICD-10 Finland

Achilles tendinitis

4.1

10.4

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

32.8

10.3

JAH01

NOMESCO Finland

Laparoscopy

2.8

10.3

234

R52.1

ICD-10 Finland

Chronic intractable pain

19.0

10.3

M76.0

ICD-10 Finland

Gluteal tendinitis

7.6

10.2

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

10.2

100

468

R09

ICPC

Sinus symptom/complaint

2.3

10.2

413

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

10.1

107

520

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.8

10.1

110

R01AD12

ATC

fluticasone furoate; nasal

1.6

10.1

324

2278

N05BA12

ATC

alprazolam; oral

2.2

10.0

108

527

R51

ICD-10 Finland

Headache

2.9

10.0

225

R05

ICD-10 Finland

Cough

1.8

10.0

192

1165

R49.01

ICD-10 Finland

Functional dysphonia

3.8

9.9

107

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.3

9.9

149

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

9.9

440

RF313

NOMESCO Finland

26.3

9.8

SFA00

NOMESCO Finland

Small filling

1.9

9.8

145

806

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

7.5

9.7

J05AB01

ATC

aciclovir; systemic

1.7

9.7

225

1445

R5599

NOMESCO Finland

Other rehabilitation service

4.8

9.7

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.9

9.7

158

908

SPAT1053

SPAT

Memory test

2.2

9.7

104

509

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

9.7

392

R03AC03

ATC

terbutaline; inhalant

1.9

9.7

149

840

M01AH03

ATC

valdecoxib; oral

2.7

9.6

243

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

9.6

190

P01BA02

ATC

hydroxychloroquine; oral

2.3

9.6

431

J01DA06

ATC

[U] cefuroxime; systemic

1.9

9.6

159

919

XQ800

NOMESCO Finland

Prick test

2.3

9.6

420

WX290

NOMESCO Finland

Other blockade of nerve

1.5

9.6

471

3648

M01AB51

ATC

indometacin, combinations; oral, rectal

5.5

9.5

L99

ICPC

Musculoskeletal disease other

5.5

9.5

SPAT1283

SPAT

Restricted health certificate

1.7

9.5

201

1256

UJH02

NOMESCO Finland

Anoscopy

3.0

9.5

176

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

9.5

107

534

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

9.5

127

678

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

9.5

202

1267

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

9.4

111

564

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

9.4

106

526

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.2

9.4

160

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

9.4

176

1056

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

100.8

9.4

M48.9

ICD-10 Finland

Spondylopathy, unspecified

+∞

9.4

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

9.4

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

+∞

9.4

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

9.4

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

9.4

259

N06AB03

ATC

fluoxetine; oral

1.9

9.3

141

789

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.4

9.3

134

J01CA04

ATC

amoxicillin; systemic

1.6

9.3

864

7667

VALMI

NOMESCO Finland

1.6

9.3

275

1888

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.9

9.3

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

9.2

551

4436

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

9.2

111

568

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

9.2

271

N80.0

ICD-10 Finland

Endometriosis of uterus

3.7

9.2

109

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.6

9.2

298

2089

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

9.2

162

954

SPAT1211

SPAT

Application of soft bandage

2.3

9.1

396

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.5

9.1

120

SPAT1325

SPAT

Vaccination

1.6

9.1

308

2183

N01

ICPC

Headache

2.1

9.1

104

521

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

9.1

104

521

C07AB02

ATC

metoprolol; systemic

1.8

9.0

163

968

G04BD08

ATC

solifenacin; oral

2.6

9.0

252

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

9.0

252

XJC10

NOMESCO Finland

Oesophageal pH monitoring

15.7

9.0

M89.0

ICD-10 Finland

Algoneurodystrophy

10.1

9.0

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.3

9.0

SPAT1310

SPAT

Counselling related to known health issue

1.6

9.0

307

2179

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

37.0

9.0

L15

ICPC

Knee symptom/complaint

1.7

9.0

198

1251

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

9.0

236

1565

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.0

9.0

166

1410

FHL

Laparoscopy

3.3

9.0

138

M05BA04

ATC

alendronic acid; oral

2.4

8.9

332

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

8.8

215

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.2

8.8

140

R03BB04

ATC

tiotropium bromide; inhalant

2.4

8.8

336

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

8.8

118

631

R11

ICD-10 Finland

Nausea and vomiting

2.4

8.8

329

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

8.8

133

746

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

8.7

138

783

J01MA06

ATC

norfloxacin; oral

1.8

8.7

148

864

G04BD12

ATC

mirabegron; oral

2.2

8.6

400

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

8.6

279

1953

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

5.8

8.6

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.9

8.6

176

WX702

NOMESCO Finland

Supraglottic ventilation device

2.5

8.6

256

J02AC02

ATC

itraconazole; systemic

1.7

8.6

194

1235

N02CC05

ATC

almotriptan; oral

2.7

8.5

214

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

3.2

8.5

133

J45

ICD-10 Finland

Asthma

2.0

8.5

102

524

XKC03

NOMESCO Finland

Water cystometry

3.7

8.4

HMAK

NOMESCO Finland

1.8

8.4

142

824

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.4

8.4

304

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

8.4

167

1023

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

5.1

8.4

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.6

8.3

229

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

+∞

8.3

XF402

NOMESCO Finland

ECG with work load test

2.1

8.3

442

XA402

NOMESCO Finland

ENMG

4.7

8.3

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.7

8.3

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.8

8.3

181

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.9

8.3

123

682

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

8.2

172

1068

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.3

8.2

120

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.3

8.2

120

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.2

8.2

367

R06AE09

ATC

levocetirizine; oral

1.7

8.2

162

991

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

6.1

8.2

G50.1

ICD-10 Finland

Atypical facial pain

4.4

8.2

N02AJ13

ATC

tramadol and paracetamol; systemic

5.7

8.2

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.6

8.1

237

D11

ICPC

Diarrhoea

2.0

8.1

109

583

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

8.1

295

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

8.1

393

3005

W19

ICD-10 Finland

Unspecified fall

2.2

8.1

406

N05CD07

ATC

temazepam; oral

2.0

8.1

103

541

P19

ICPC

Drug abuse

11.8

8.1

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

8.0

231

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

8.0

282

2006

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

8.0

310

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.2

8.0

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

3.6

8.0

P03

ICPC

Feeling depressed

2.0

8.0

492

D19

ICPC

Teeth/gum symptom/complaint

1.5

8.0

271

1915

R96

ICPC

Asthma

2.1

8.0

442

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.7

7.9

193

ZX114

NOMESCO Finland

Intramuscular

5.2

7.9

C10AA07

ATC

rosuvastatin; oral

1.6

7.8

199

1307

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.0

7.8

103

547

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.1

7.8

ZX120

NOMESCO Finland

Intravenous

2.0

7.8

481

WX402

NOMESCO Finland

General anaesthesia

1.7

7.8

171

1079

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

5.1

7.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

7.7

271

N76.0

ICD-10 Finland

Acute vaginitis

2.3

7.7

336

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

7.7

501

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.0

7.7

138

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

7.6

122

695

A67

ICPC

General and Unspecified, Referral to physician/hospital

18.5

7.6

M77.4

ICD-10 Finland

Metatarsalgia

2.5

7.6

247

R07.0

ICD-10 Finland

Pain in throat

2.3

7.6

319

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.5

7.6

229

L83

ICPC

Neck syndrome

8.9

7.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.0

7.5

149

R13

ICD-10 Finland

Dysphagia

2.4

7.5

249

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.5

7.5

241

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

7.5

719

6242

R05

ICPC

Cough

1.6

7.4

215

1459

C01DA14

ATC

isosorbide mononitrate; oral

2.1

7.4

412

F34.1

ICD-10 Finland

Dysthymia

2.8

7.4

174

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

80.6

7.4

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

80.6

7.4

N41.1

ICD-10 Finland

Chronic prostatitis

5.3

7.4

G56.4

ICD-10 Finland

Causalgia

13.5

7.4

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

7.4

443

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

7.4

457

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

7.4

416

N06AB06

ATC

sertraline; oral

1.9

7.4

116

658

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

7.4

298

Z97.4

ICD-10 Finland

Presence of external hearing-aid

3.3

7.3

109

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

7.3

401

3128

N30.0

ICD-10 Finland

Acute cystitis

1.8

7.3

138

829

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.0

7.3

474

SPAT1255

SPAT

Intravenous administration of medicine

2.3

7.3

279

G44.0

ICD-10 Finland

Cluster headache syndrome

6.9

7.3

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

7.3

7225A

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]

+∞

7.3

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

+∞

7.3

M41.2

ICD-10 Finland

Other idiopathic scoliosis

+∞

7.3

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

9.4

7.3

M75.8

ICD-10 Finland

Other shoulder lesions

3.1

7.3

121

N02CC03

ATC

zolmitriptan; nasal, oral

2.2

7.3

325

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

5.8

7.2

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

3.6

7.2

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

7.2

328

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

7.4

7.2

H03AA01

ATC

levothyroxine sodium; systemic

1.5

7.2

250

1770

M01AE51

ATC

ibuprofen, combinations; systemic

4.9

7.2

N64.4

ICD-10 Finland

Mastodynia

3.0

7.2

128

G04BD07

ATC

tolterodine; oral

2.7

7.1

174

R35

ICD-10 Finland

Polyuria

2.6

7.1

199

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.5

7.1

N02CC04

ATC

rizatriptan; oral

2.1

7.1

380

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

3.3

7.1

101

R03AC13

ATC

formoterol; inhalant

2.6

7.1

192

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

6.1

7.1

R05DA01

ATC

ethylmorphine; oral

2.0

7.1

450

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

7.1

381

XJC00

NOMESCO Finland

Oesophageal manometry

12.1

7.1

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.1

7.1

395

R01AD05

ATC

budesonide; nasal

2.1

7.0

396

PAW37

NOMESCO Finland

Biopsy of temporal artery

10.1

7.0

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.3

7.0

259

A06AD11

ATC

lactulose; oral

1.9

7.0

106

592

R03BA05

ATC

fluticasone; inhalant

1.6

7.0

173

1125

J37.0

ICD-10 Finland

Chronic laryngitis

3.2

7.0

113

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

7.0

375

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.8

7.0

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.8

7.0

M70.7

ICD-10 Finland

Other bursitis of hip

3.8

7.0

NA3BG

SPAT

3.9

7.0

R02

ICPC

Shortness of breath/dyspnoea

1.9

7.0

104

579

E0000UV

ATC

1.4

7.0

388

3027

UDM02

NOMESCO Finland

Sinoscopy

3.6

6.9

N03AX11

ATC

topiramate; oral

3.2

6.9

109

RT272

NOMESCO Finland

13.9

6.9

H01

ICPC

Ear pain/earache

1.9

6.9

103

573

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.4

6.9

R74

ICPC

Upper respiratory infection acute

1.5

6.9

294

2177

C09CA06

ATC

candesartan; oral

1.6

6.8

200

1356

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

6.8

269

N62

ICD-10 Finland

Hypertrophy of breast

2.5

6.8

210

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

6.8

229

J01CA08

ATC

pivmecillinam; oral

1.4

6.8

463

3743

R50.9

ICD-10 Finland

Fever, unspecified

1.8

6.8

117

685

R60.0

ICD-10 Finland

Localized oedema

2.0

6.8

458

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

3.8

6.8

A02BA03

ATC

famotidine; systemic

3.1

6.8

116

M25.2

ICD-10 Finland

Flail joint

5.7

6.8

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

6.7

135

829

R06.5

ICD-10 Finland

Mouth breathing

2.1

6.7

393

A97

ICPC

No disease

1.7

6.7

136

835

H92.0

ICD-10 Finland

Otalgia

2.3

6.7

252

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

6.7

205

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.7

6.7

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

6.7

425

SPAT1360

SPAT

Extensive global examination

2.2

6.6

300

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.2

6.6

H02.3

ICD-10 Finland

Blepharochalasis

2.3

6.6

267

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

6.6

362

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.0

6.6

124

A07AA02

ATC

nystatin; oral

2.3

6.6

258

N80.9

ICD-10 Finland

Endometriosis, unspecified

3.7

6.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

6.6

268

L16

ICPC

Ankle symptom/complaint

1.9

6.6

477

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

6.6

293

Z30.2

ICD-10 Finland

Sterilization

1.7

6.6

133

818

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.4

6.6

D06

ICPC

Abdominal pain localized other

2.0

6.5

421

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

10.1

6.5

S44

ICPC

Skin, Preventive immunization/medic

3.7

6.5

ZXC60

NOMESCO Finland

Application of heat

3.7

6.5

SPAT1254

SPAT

Administration of medicine

1.8

6.5

114

672

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.2

6.5

G83.4

ICD-10 Finland

Cauda equina syndrome

70.2

6.4

NEK99

NOMESCO Finland

Other operation on bone of pelvis

70.2

6.4

J46

ICD-10 Finland

Status asthmaticus

3.6

6.4

G01AA10

ATC

clindamycin; vaginal

1.6

6.4

187

1268

R21

ICPC

Throat symptom/complaint

1.6

6.4

198

1360

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

3.8

6.4

R01AD11

ATC

triamcinolone; nasal

1.9

6.4

493

M03BX01

ATC

baclofen; systemic

4.9

6.4

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.7

6.4

155

R03BA08

ATC

ciclesonide; inhalant

1.9

6.3

465

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

6.3

118

708

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

6.6

6.3

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

6.3

189

XA420

NOMESCO Finland

Extensive sleep examination

6.0

6.3

S06.0

ICD-10 Finland

Concussion

1.9

6.3

455

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

6.3

182

OAA65

SPAT

1.8

6.3

100

568

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

11.1

6.3

R15

ICD-10 Finland

Faecal incontinence

3.3

6.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.2

6.3

100

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

18.1

6.3

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

6.3

202

7249X

ICD-9 Finland

Other and unspecified disorders of back, Other unspecified back disorders

+∞

6.3

T91.2

ICD-10 Finland

Sequelae of other fracture of thorax and pelvis

+∞

6.3

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

6.3

M96.8

ICD-10 Finland

Other postprocedural musculoskeletal disorders

+∞

6.3

M50.2

ICD-10 Finland

Other cervical disc displacement

+∞

6.3

NAT99

NOMESCO Finland

Other operation on spine, unspecified

+∞

6.3

R12

ICD-10 Finland

Heartburn

2.1

6.2

323

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.5

6.2

RT274

NOMESCO Finland

26.8

6.2

M99.0

ICD-10 Finland

Segmental and somatic dysfunction

26.8

6.2

G57.0

ICD-10 Finland

Lesion of sciatic nerve

26.8

6.2

M75.2

ICD-10 Finland

Bicipital tendinitis

3.1

6.2

101

L12

ICPC

Hand/finger symptom/complaint

1.7

6.2

125

770

L18

ICPC

Muscle pain

2.7

6.2

152

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.4

6.2

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.1

6.1

305

R61

ICD-10 Finland

Hyperhidrosis

7.7

6.1

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

6.1

249

J01DA08

ATC

[U] cefaclor; oral

1.7

6.1

114

682

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

4.1

6.1

R25.2

ICD-10 Finland

Cramp and spasm

3.6

6.1

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

6.1

428

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.9

6.1

C03CA01

ATC

furosemide; systemic

1.6

6.0

179

1218

UJD02

NOMESCO Finland

Gastroscopy

2.5

6.0

181

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.5

6.0

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

10.1

6.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

6.0

405

P01

ICPC

Feeling anxious/nervous/tense

1.8

6.0

100

580

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.2

6.0

XF404

NOMESCO Finland

Ambulatory ECG

2.0

6.0

392

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.7

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

374

1575

2.98

62.08

1.4

1.2

u/ml

7.2

13.4

1.28

123

632

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

375

1672

2.79

55.04

1.4

1.2

iu/ml

22.3

28.6

0.53

105

547

(3013707) Erythrocyte sedimentation rate by Westergren method

977

7071

2.90

50.00

5.2

3.6

mm/h

10.1

11.4

3.33

937

6551

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

306

1287

2.84

49.58

3.1

2.4

e6/l

0.7

1.2

1.07

178

687

(3030467) Casts [#/volume] in Urine by Automated count

440

2217

2.54

49.56

3.8

2.6

e6/l

0.1

0.5

7.34

322

1614

(3018095) Leukocytes [#/volume] in Urine

538

3016

2.40

47.45

4.3

3.1

e6/l

66.5

103.2

0.75

381

2001

(36304419) Bacteria [Presence] in Urine

433

2202

2.50

47.43

3.8

2.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

525

2929

2.39

46.61

4.0

2.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

291

1228

2.80

46.55

3.2

2.5

e6/l

2.6

3.3

0.74

164

633

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

450

2385

2.40

44.43

2.3

2.0

u/l

119.4

218.3

1.74

422

2244

(3001604) Monocytes [#/volume] in Blood

719

4660

2.32

44.12

5.9

5.5

e9/l

0.5

0.6

0.32

620

4055

(3006315) Basophils [#/volume] in Blood

719

4678

2.30

43.46

6.0

5.6

e9/l

0.0

0.63

621

4072

(3013115) Eosinophils [#/volume] in Blood

738

4856

2.31

43.39

6.1

5.8

e9/l

0.2

0.36

673

4286

(3002582) Erythrocytes [#/volume] in Urine

458

2469

2.37

43.28

3.8

2.7

e6/l

42.4

123.2

1.37

342

1847

(3019198) Lymphocytes [#/volume] in Blood

732

4827

2.29

42.43

6.0

5.5

e9/l

2.2

1.9

0.80

665

4281

(3013650) Neutrophils [#/volume] in Blood by Automated count

796

5474

2.30

41.14

7.5

9.1

e9/l

4.0

0.11

682

4805

(3037522) Nuclear Ab [Titer] in Serum

286

1289

2.59

39.49

1.5

1.3

titre

640.8

565.3

0.20

280

(3031040) Bacteria [#/volume] in Urine by Automated count

852

6120

2.29

38.29

5.4

3.7

e6/l

158.1

2402.2

—

(3000850) Epithelial cells [#/volume] in Urine

335

1655

2.41

37.77

2.7

2.2

e6/l

5.1

8.1

2.92

290

1443

(3033658) Prothrombin time (PT) actual/Normal

408

2228

2.25

36.14

4.4

3.4

96.9

94.5

1.22

402

2167

(3026782) Osmolality of Urine

320

1585

2.38

35.60

3.0

2.4

mosm/kgh2o

525.3

539.1

0.53

276

1356

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

646

4246

2.11

35.22

5.7

6.2

mmol/l

1.2

0.83

568

3583

(3022096) Basophils/100 leukocytes in Blood

650

4288

2.10

35.02

6.1

5.6

0.7

0.84

599

3999

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

306

1504

2.38

34.52

3.6

3.1

ng/l

36.2

353.2

4.81

203

1024

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

943

7207

2.35

34.43

7.7

7.0

u/l

73.2

76.8

2.81

878

6778

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

547

3403

2.10

34.27

2.1

1.8

pmol/l

96.8

97.7

0.16

260

1751

(3037467) Urinalysis macro (dipstick) panel - Urine

874

6493

2.21

33.93

5.2

3.8

—

(3019069) Monocytes/100 leukocytes in Blood

664

4461

2.07

33.52

6.3

5.8

8.2

8.3

0.85

617

4187

(3006504) Eosinophils/100 leukocytes in Blood

659

4436

2.05

32.85

6.2

5.6

2.8

0.01

612

4134

(3024561) Albumin [Mass/volume] in Serum or Plasma

571

3676

2.04

31.92

4.3

4.6

g/l

36.9

36.0

4.02

535

3430

(42870588) Differential panel, method unspecified - Blood

492

3005

2.07

31.77

5.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

580

3797

2.00

30.51

5.4

5.3

mmol/l

1.2

1.28

542

3450

(3002030) Lymphocytes/100 leukocytes in Blood

672

4633

2.00

30.45

6.2

5.6

29.9

28.8

1.97

620

4332

(3018418) pH of Serum or Plasma

421

2467

2.08

30.07

3.5

3.6

7.4

0.22

500

(3018010) Neutrophils/100 leukocytes in Blood

664

4573

1.99

30.02

6.2

5.5

55.4

56.8

2.59

618

4297

(3048689) Calprotectin [Mass/mass] in Stool

239

1141

2.36

28.26

2.3

2.2

ug/g

86.2

107.8

0.99

202

899

(3026493) Urate [Moles/volume] in Serum or Plasma

391

2273

2.06

28.20

2.3

2.4

umol/l

2863.0

4648.0

0.42

330

2013

(3013826) Glucose [Moles/volume] in Serum or Plasma

712

5109

1.94

27.59

4.7

4.2

mmol/l

6.4

6.6

2.90

671

4711

(3014051) Protein [Presence] in Urine by Test strip

178

4.30

27.47

1.9

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

655

4588

1.92

27.12

4.1

3.1

estimate

0.0

0.00

861

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

993

8045

2.25

27.00

4.9

4.1

pmol/l

14.5

14.6

0.26

937

7413

(3011397) Hemoglobin [Presence] in Urine by Test strip

353

2015

2.06

26.49

4.2

3.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

656

4632

1.90

26.14

5.6

4.3

estimate

0.0

0.50

874

(3001122) Ferritin [Mass/volume] in Serum or Plasma

637

4465

1.89

25.87

3.2

2.7

ug/l

97.1

99.9

0.15

609

4162

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1102

9403

2.74

25.62

6.0

4.7

mu/l

1.7

2.2

1.46

1053

8707

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

14.63

25.40

1.3

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

350

2024

2.02

25.14

1.9

1.6

mg/l

0.8

1.0

1.96

264

1507

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1146

10005

3.31

25.03

16.5

11.0

mg/l

18.4

22.3

4.43

951

7667

(3009261) Glucose [Presence] in Urine by Test strip

655

4663

1.87

25.03

4.2

3.1

estimate

0.0

1.32

857

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

655

4668

1.87

24.89

5.4

6.1

umol/l

9.8

10.9

2.97

630

4439

(3007164) IgA [Mass/volume] in Serum or Plasma

331

1893

2.03

24.42

1.5

1.4

g/l

2.2

2.3

0.60

177

1203

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

180

808

2.44

24.20

2.6

2.1

u/l

150.0

42.5

0.43

151

698

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

368

2200

1.96

23.83

1.4

1.2

u/ml

2.0

1.6

0.16

593

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

1016

2.25

22.57

2.4

2.5

umol/l

4.2

7.5

7.05

184

879

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

425

2711

1.87

22.33

2.6

2.4

u/l

56.7

57.8

0.19

394

2510

(40758558) Short blood count panel - Blood

381

2366

1.89

21.65

6.2

6.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

146

632

2.49

21.13

2.5

2.4

au/ml

32.0

19.0

—

(3008898) HLA-B27 [Presence]

313

3.10

21.09

1.1

—

(3026008) Bacteria identified in Urine by Culture

411

2662

1.82

20.13

3.6

2.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

343

2108

1.87

19.85

2.3

2.1

mg/l

2.6

3.0

2.87

305

1797

(3045414) Leukocytes [Presence] in Urine

104

392

2.81

19.84

1.7

1.8

—

(3019150) Specific gravity of Urine by Refractometry

309

1870

1.87

18.60

4.6

3.3

kg/l

1.0

0.18

285

(3044889) 12 lead EKG panel

831

6682

1.76

18.29

3.9

3.2

—

(40768797) Stomach Pathology biopsy report

220

1194

2.03

18.23

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

551

3977

1.70

17.91

2.6

2.2

nmol/l

77.1

77.2

0.04

501

3632

(3015171) Extractable nuclear Ab [Units/volume] in Serum

349

2.80

17.87

1.3

1.2

u/ml

4.1

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

466

3218

1.72

17.80

3.4

3.1

u/l

27.3

31.0

2.34

449

3078

(3023103) Potassium [Moles/volume] in Serum or Plasma

1138

10210

2.65

17.63

16.9

12.3

mmol/l

3.9

0.29

1123

9897

(3019550) Sodium [Moles/volume] in Serum or Plasma

1134

10172

2.58

17.30

16.7

12.2

mmol/l

139.8

139.7

1.05

1120

9885

(3025941) Bacteria identified in Stool by Culture

119

530

2.38

16.08

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

405

2.57

16.06

3.3

3.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

161

824

2.10

15.51

1.9

2.0

nmol/l

346.4

380.6

1.56

147

759

(3022621) pH of Urine by Test strip

126

585

2.29

15.47

2.8

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

251

1499

1.85

15.44

2.5

2.8

mmol/l

2.4

1.40

207

1332

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1176

10830

3.23

15.39

11.8

9.0

u/l

26.0

25.1

1.20

1149

10486

(3006462) Nitrate [Presence] in Urine

7.90

15.32

1.4

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

311

1999

1.75

14.88

1.7

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

314

2032

1.73

14.63

2.4

2.8

ng/l

584.9

1034.1

4.25

251

1701

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1088

9721

2.08

14.60

4.9

4.0

mmol/l

5.8

0.61

1045

8952

(3004789) Transferrin [Mass/volume] in Serum or Plasma

202

1149

1.91

14.38

2.2

g/l

2.5

2.4

1.26

188

1065

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

832

6899

1.64

14.23

3.5

2.8

u/l

45.0

43.0

0.22

800

6511

(3019309) Folate [Moles/volume] in Red Blood Cells

230

1370

1.84

14.16

1.8

1.7

nmol/l

1091.7

1156.9

0.52

181

1045

(3003327) Ova and parasites identified in Stool by Light microscopy

314

2.66

14.10

1.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

430

3049

1.63

14.05

3.6

3.0

ng/l

37.6

51.7

0.35

242

1811

(3002385) Erythrocyte distribution width [Ratio]

991

8625

1.79

13.95

19.1

13.9

13.6

0.13

980

8438

(3015377) Calcium [Moles/volume] in Serum or Plasma

432

3076

1.63

13.84

2.8

3.4

mmol/l

2.4

0.58

393

2758

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

578

4412

1.59

13.83

3.7

3.8

—

(3021589) Normoblasts [#/volume] in Blood

566

4304

1.59

13.74

9.2

8.6

e9/l

0.0

0.50

446

3525

(3000570) Elastase.pancreatic [Mass/mass] in Stool

227

2.92

13.65

1.3

ug/g

325.8

305.9

0.32

128

(4211845)

6.88

13.61

1.4

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

288

1853

1.72

13.57

1.6

1.4

nmol/l

21.1

21.2

0.01

258

1581

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

186

1055

1.90

13.30

2.2

2.3

21.9

23.1

0.55

164

907

(3012095) Magnesium [Moles/volume] in Serum or Plasma

218

1302

1.82

13.24

2.7

3.6

mmol/l

0.8

0.34

206

1223

(3022145) Colonoscopy Study observation

178

997

1.92

13.22

1.4

1.3

—

(3000492) Spirometry study

172

955

1.93

13.11

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

212

1260

1.83

13.07

2.2

umol/l

14.2

13.4

0.72

197

1156

(3014765) Yersinia sp identified in Stool by Organism specific culture

273

2.70

13.04

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1021

9026

1.79

12.83

5.8

4.9

mmol/mol

38.2

39.0

2.41

976

8406

(40768804) Tissue Pathology biopsy report

542

4155

1.55

12.23

2.1

2.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

4.55

12.17

1.1

titre

208.6

114.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

277

2.62

12.16

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

170

966

1.88

12.04

2.0

1.6

—

(3023368) Bacteria identified in Blood by Culture

299

2013

1.64

11.66

4.1

4.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1062

9573

1.83

11.52

13.7

10.3

ml/min/173m2

85.7

84.5

1.15

904

7806

(3009542) Hematocrit [Volume Fraction] of Blood

1063

9585

1.83

11.52

17.8

12.0

40.1

39.8

0.85

852

7407

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

148

816

1.93

11.47

1.8

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

120

615

2.05

11.44

1.7

1.6

—

(4010399)

118

601

2.07

11.44

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

269

2.58

11.31

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

477

3603

1.53

11.25

4.4

3.1

—

(36660697) Celiac disease serology panel - Serum

142

780

1.93

11.12

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

145

808

1.90

10.87

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

101

499

2.12

10.61

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

142

794

1.89

10.53

2.0

1.7

—

(40761511) CBC panel - Blood by Automated count

1148

10687

2.21

10.39

14.0

10.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

114

594

2.01

10.38

2.0

2.7

g/l

67.5

67.1

0.23

102

549

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

199

2.74

10.23

1.1

1.2

u/ml

107.4

27.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

272

2.47

10.09

1.2

—

34.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

829

7122

1.51

9.94

3.7

3.1

—

(3044640) Blood type and Crossmatch panel - Blood

394

2920

1.52

9.86

2.3

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

263

2.43

9.36

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

1201

11473

3.60

9.26

23.6

16.6

e9/l

261.2

259.9

0.31

1180

11189

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

192

1220

1.68

9.19

1.7

—

(3042936) Bacteria identified in Isolate by Culture

181

1134

1.70

9.13

2.1

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

116

3.17

9.12

1.6

1.3

—

(3024731) MCV [Entitic volume]

1201

11481

3.56

9.08

23.5

16.5

91.0

90.7

1.67

1194

11322

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1107

10248

1.85

9.07

5.2

4.3

mmol/l

2.9

0.30

1064

9554

(3035941) MCH [Entitic mass]

1201

11483

3.55

9.04

23.5

16.5

30.3

30.2

2.45

1194

11323

(3026361) Erythrocytes [#/volume] in Blood

1201

11484

3.55

9.02

23.6

16.5

e12/l

4.5

0.09

1185

11174

(3032080) INR in Blood by Coagulation assay

420

3201

1.48

8.99

6.3

7.6

inr

1.1

1.2

0.74

101

1032

(3010813) Leukocytes [#/volume] in Blood

1201

11487

3.53

8.95

23.6

16.6

e9/l

6.8

6.6

0.80

1185

11171

(3000963) Hemoglobin [Mass/volume] in Blood

1201

11491

3.51

8.87

23.7

16.6

g/l

135.0

134.6

0.50

1194

11332

(3027945) Reticulocytes/100 erythrocytes in Blood

138

810

1.79

8.74

2.3

2.9

1.7

1.8

0.48

129

731

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

303

2171

1.53

8.72

2.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

261

2.37

8.59

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

295

2.27

8.45

1.5

2.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1091

10095

1.75

8.43

4.6

4.0

mmol/l

4.8

0.32

1050

9466

(3005322) IgE [Units/volume] in Serum or Plasma

115

646

1.86

8.40

1.3

u/ml

246.4

195.3

0.23

108

600

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

240

2.40

8.30

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

332

2.18

8.19

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

267

2.31

8.17

1.9

2.0

g/l

10.3

0.00

227

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

158

2.72

8.12

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

158

2.72

8.12

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

529

1.93

8.08

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

417

2.04

8.01

2.4

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1055

9706

1.63

7.96

4.0

3.6

mmol/l

1.3

3.38

1008

9014

(3023323) Follitropin [Units/volume] in Serum or Plasma

120

695

1.81

7.94

1.4

1.3

iu/l

26.5

30.9

0.76

107

608

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

100

548

1.90

7.88

2.2

2.1

ug/l

3.8

7.1

3.19

487

(3052851) Hemolysis interference index of Serum or Plasma

240

2.35

7.84

2.1

3.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

2.27

7.84

2.0

g/l

3.0

3.1

0.46

215

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

549

1.87

7.53

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1082

10048

1.67

7.49

4.5

3.9

mmol/l

1.5

3.03

1039

9372

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

285

2.20

7.43

2.0

g/l

3.6

3.8

0.79

206

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

180

1186

1.61

7.40

1.9

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

2.83

7.37

2.1

1.8

g/l

0.7

0.9

0.44

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

2.19

7.37

2.0

g/l

7.1

7.3

0.39

218

(3017143) Hepatitis C virus Ab [Presence] in Serum

172

1125

1.62

7.29

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

129

2.76

7.07

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

156

1005

1.63

7.02

3.7

5.9

mmol/l

1.0

0.28

150

943

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

2.15

6.97

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

428

1.93

6.80

1.7

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

107

630

1.77

6.71

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

557

1.81

6.62

2.2

2.9

ng/l

100.7

203.1

3.32

492

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

186

1271

1.55

6.51

2.3

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

304

2301

1.43

6.38

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

102

605

1.75

6.25

2.7

3.6

ng/l

70.0

80.3

1.17

534

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

383

1.93

6.24

1.8

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

104

624

1.73

6.12

8.3

6.4

mmol/l

1.3

0.04

603

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

322

2.01

6.12

2.9

mmol/l

25.2

24.0

2.28

298

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

110

671

1.70

6.10

3.3

3.5

pmol/l

4.6

4.5

0.06

591

(40761535) Cells panel - Urine sediment

100

594

1.74

6.10

4.5

3.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

109

666

1.70

6.01

2.3

2.7

g/l

10.6

10.5

0.08

100

607

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

109

667

1.70

5.98

2.6

2.3

ml/min/173m2

64.8

69.5

0.45

263

(3004716) Salmonella sp identified in Stool by Organism specific culture

568

1.75

5.94

1.3

1.4

—

(3000991) Gas panel - Venous blood

596

1.72

5.77

9.0

7.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

388

1.88

5.70

2.0

2.1

u/l

40.4

39.2

0.18

349

(3000494) Fungus identified in Specimen by Culture

158

1077

1.54

5.58

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

428

1.83

5.56

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

127

832

1.59

5.34

1.2

iu/ml

62.4

142.1

3.15

334

(3038177) Helicobacter pylori Ab [Presence] in Serum

182

2.24

5.27

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

334

1.90

5.22

1.4

1.6

—

15.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

244

2.05

5.15

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

163

1138

1.50

5.14

1.4

1.7

1.5

1.4

0.88

135

1030

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.78

5.10

1.2

1.1

iu/ml

99.3

253.8

2.05

(4198724)

4.23

5.10

3.8

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

130

871

1.55

4.97

20.2

19.8

inr

1.3

0.05

136

(46235355) HIV 1 and 2 tests - Meaningful Use set

258

1981

1.38

4.85

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

387

1.80

4.84

12.2

12.3

—

(4094501)

244

2.01

4.79

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

178

2.17

4.69

2.5

1.7

nmol/l

39.8

41.6

0.19

171

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

121

2.43

4.66

2.7

1.6

pmol/l

155.7

206.3

1.47

112

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

126

853

1.53

4.60

3.2

4.7

u/l

223.0

250.4

1.87

120

810

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

263

1.94

4.55

1.2

1.3

—

(3002032) Base excess in Venous blood by calculation

635

1.59

4.34

2.7

2.9

mmol/l

2.5

1.8

1.26

510

(3000475) Leukocytes [#/volume] in Synovial fluid

171

2.14

4.32

1.6

e6/l

9312.8

13418.8

0.31

124

(3028026) IgM [Mass/volume] in Serum or Plasma

526

1.64

4.28

2.1

1.8

g/l

1.2

1.6

1.22

485

(3023520) Reticulocytes [#/volume] in Blood

585

1.60

4.18

2.2

3.1

e9/l

71.9

72.7

0.10

439

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.01

4.13

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.78

4.09

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

156

1130

1.44

4.08

2.0

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

169

2.10

4.04

1.1

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

136

2.24

4.04

1.7

2.3

—

(3002619) Bacteria identified in Specimen by Culture

6.47

3.98

1.0

—

(3025130) Human papilloma virus identified in Specimen

205

1.98

3.95

1.7

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

298

2412

1.31

3.88

5.0

3.3

estimate

0.0

0.88

870

(3049717) Cytology report of Urine Cyto stain

222

1.92

3.81

2.1

2.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

119

830

1.48

3.80

8.5

8.1

kpa

5.2

5.1

0.80

113

806

(3027801) Oxygen [Partial pressure] in Arterial blood

119

830

1.48

3.80

8.5

8.1

kpa

13.2

13.1

0.06

111

804

(3002173) Hemoglobin [Mass/volume] in Arterial blood

102

689

1.52

3.79

9.9

9.1

g/l

121.9

120.7

0.26

670

(3016502) Oxygen saturation in Arterial blood

106

722

1.51

3.79

9.2

8.8

96.1

96.2

0.04

101

703

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.66

3.74

1.5

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

276

1.81

3.67

1.1

u/ml

1.0

5.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

314

2579

1.29

3.64

1.6

mmol/l

1.5

1.4

1.22

273

2189

(3047007) Chlamydophila sp Ab [Presence] in Serum

143

2.13

3.61

1.3

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

3.19

3.50

2.3

2.1

—

124.2

—

(3003396) Base excess in Arterial blood by calculation

117

829

1.45

3.46

9.2

8.1

mmol/l

1.2

1.1

0.20

674

(40760892) CBC W Ordered Manual Differential panel - Blood

274

2226

1.30

3.44

4.1

4.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

2.10

3.39

1.2

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.27

3.34

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.94

3.30

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

116

2.18

3.24

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.52

3.22

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.52

3.22

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.52

3.22

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

157

2.00

3.21

1.2

1.0

u/ml

1.4

2.1

0.64

(4062490)

2.43

3.14

2.1

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

209

1656

1.32

3.14

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.53

3.11

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.82

3.09

1.1

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

112

806

1.43

3.07

2.0

2.2

g/l

0.2

0.13

105

772

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.45

3.05

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.45

3.05

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.45

3.05

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

319

2679

1.26

3.03

3.5

2.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

190

1.87

2.99

1.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

293

2441

1.26

2.98

2.9

3.3

mg/l

844.7

427.2

0.42

165

1493

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

4.73

2.92

1.1

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.73

2.92

1.3

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.41

2.87

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

129

964

1.38

2.86

8.7

5.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

148

1132

1.35

2.84

5.0

3.6

21.1

0.02

502

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

172

1.88

2.83

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

102

739

1.41

2.72

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

146

1.94

2.71

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

182

1.84

2.71

1.1

u/ml

0.3

2.0

1.64

(3009508) Creatinine [Moles/volume] in Urine

313

2657

1.24

2.67

3.0

3.1

mmol/l

7.5

7.4

0.22

253

2275

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.14

2.65

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.14

2.65

1.0

1.4

—

(4027681)

2.56

2.62

1.1

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

170

1.84

2.60

1.2

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.62

2.57

2.0

1.1

nmol/l

101.6

116.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

261

1.67

2.57

2.3

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

228

1875

1.27

2.57

1.7

1.6

pmol/l

80628713.0

33586285.4

0.37

191

1584

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

263

1.66

2.50

1.6

iu/ml

0.0

0.3

0.57

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

382

1.54

2.50

12.9

9.1

mmol/l

24.4

24.3

0.12

368

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

103

2.06

2.42

1.4

pmol/l

272.0

313.4

0.26

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

213

1.71

2.38

1.1

u/ml

0.5

1.5

0.71

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

6.27

2.37

1.0

1.3

—

(3011288) Drugs identified in Urine by Screen method

237

1.67

2.34

7.8

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

119

1.95

2.31

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

174

1403

1.28

2.30

5.2

4.3

ug/l

1.7

2.3

1.31

162

1264

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.63

2.27

1.0

1.1

111.2

94.0

—

(3004616) Nuclear Ab [Presence] in Serum

127

1.91

2.27

1.4

1.3

—

(3047181) Lactate [Moles/volume] in Blood

232

1.66

2.25

4.7

10.3

mmol/l

1.0

1.3

2.42

206

(3019060) Gas panel - Arterial blood

450

1.47

2.24

4.3

6.5

—

(3024263) Appearance of Synovial fluid

2.79

2.20

1.4

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

180

1.74

2.20

1.7

2.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.51

2.19

1.0

1.1

nmol/l

0.3

1.7

—

(3016879) Cocaine [Presence] in Urine

322

1.54

2.17

2.3

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

189

1.71

2.15

1.1

u/ml

1.6

5.3

1.86

(3010726) Horse dander IgE Ab [Units/volume] in Serum

175

1.73

2.11

1.1

u/ml

0.2

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.99

2.06

1.2

1.3

nmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

3.51

2.05

2.6

3.5

—

(44806420)

3.51

2.05

1.4

2.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.51

2.05

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.41

2.03

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.41

2.03

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

133

1.82

2.00

1.7

2.1

umol/l

5.4

5.5

0.01

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

210

1.64

1.96

2.9

3.3

mg/l

21.2

43.2

0.90

171

(3021788) Differential panel - Synovial fluid

134

1.81

1.96

1.5

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.95

1.96

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.20

1.94

1.3

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

414

1.45

1.94

2.9

2.7

g/l

127.8

128.5

0.09

400

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.76

1.93

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.76

1.93

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.76

1.93

1.0

—

(3034426) Prothrombin time (PT)

2.74

1.93

1.3

1.1

—

(3027944) Amphetamines [Presence] in Urine

348

1.49

1.92

2.3

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.01

1.90

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.19

1.88

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.19

1.88

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

350

1.48

1.88

2.3

1.7

—

(3027008) Opiates [Presence] in Urine

350

1.48

1.88

2.3

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

151

1.74

1.88

1.1

1.9

—

(3024928) Oxygen saturation in Venous blood

144

1.75

1.86

3.5

2.7

—

(3002256) Pathology report gross observation

161

1324

1.25

1.83

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

108

1.87

1.82

6.3

4.7

u/ml

22.1

78.0

—

(3028300) Cannabinoids [Presence] in Urine

353

1.46

1.81

2.3

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

110

866

1.30

1.79

3.4

2.7

ug/l

0.5

0.7

4.12

524

(3013512) EKG study

286

2500

1.19

1.77

3.5

3.2

—

(3006653) Thiamine [Moles/volume] in Blood

2.45

1.75

1.6

1.4

nmol/l

131.0

134.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.04

1.75

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

209

1.60

1.75

3.0

3.3

mg/l

37.9

81.1

0.77

169

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.51

1.74

1.7

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.93

1.72

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.93

1.72

1.0

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.93

1.72

1.0

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

442

1.40

1.71

6.8

8.5

mmol/l

25.1

24.6

0.57

420

(3035320) C reactive protein [Mass/volume] in Body fluid

2.11

1.66

3.2

2.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.81

1.65

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.58

1.61

1.2

2.2

mmol/l

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.51

1.60

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.70

1.58

1.1

1.0

—

(3020891) Body temperature

258

1.49

1.52

3.9

3.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

116

1.74

1.49

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

291

2583

1.17

1.49

3.5

4.0

mg/mmol

8.8

7.4

0.12

143

1606

(3020779) Urea [Moles/volume] in Serum or Plasma

631

1.30

1.46

4.5

8.0

mmol/l

7.4

8.8

1.16

604

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

1.45

1.3

1.1

—

(4146454)

1.93

1.44

2.7

3.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.13

1.44

1.0

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.74

1.43

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

157

1.60

1.41

1.0

u/ml

1.4

2.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

189

1.55

1.41

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

189

1.55

1.41

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

138

1152

1.22

1.40

1.5

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.18

1.40

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.42

1.39

1.0

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.90

1.39

3.1

1.8

nmol/l

17.2

19.7

0.68

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.09

1.38

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.01

1.38

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.95

1.36

1.4

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

428

1.35

1.34

2.6

3.5

mmol/l

0.8

2.0

1.94

320

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

1.34

0.0

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

308

1.41

1.33

2.0

1.9

g/l

1.4

1.5

0.22

261

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.98

1.33

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

448

1.33

1.30

2.6

3.6

kpa

5.0

5.2

1.97

425

(3009343) pH of Capillary blood

442

1.33

1.25

2.6

3.6

7.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.41

1.24

1.3

10.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

155

1.56

1.23

1.2

1.3

—

72.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.01

1.23

1.3

2.3

—

(4268621)

116

1.65

1.21

3.2

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.80

1.21

2.5

2.8

—

(40768443) Skin Pathology biopsy report

376

1.34

1.19

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

173

1.51

1.18

1.5

1.2

u/ml

2.6

2.8

0.06

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.01

1.16

1.9

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.06

1.15

1.3

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

142

1.56

1.14

1.0

1.1

u/ml

1.5

4.0

—

(3023410) Appearance of Cerebral spinal fluid

1.69

1.14

1.3

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.85

1.13

1.4

2.2

—

(44813793)

1.90

1.12

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.01

1.12

1.3

1.0

miu/ml

1453.5

1648.9

—

(3005033) Fetal Nuchal fold Thickness US

294

1.37

1.11

1.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

176

1.49

1.11

1.5

1.2

u/ml

3.7

3.2

0.15

(4133840)

2.39

1.09

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

295

1.37

1.09

1.5

1.4

—

(3017704) Immunofixation for Urine

1.96

1.09

1.1

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.19

1.08

1.0

u/ml

27.6

36.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

103

861

1.21

1.08

3.2

4.3

ug/l

6.6

21.3

0.80

669

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

472

1.29

1.06

2.2

1.9

u/l

10537.3

3036.3

0.76

204

(1761868) Lipid panel - Serum or Plasma

386

4159

0.89

1.04

2.6

—

(3047189) Immunofixation for 24 hour Urine

2.06

1.03

1.3

2.1

—

(4034850)

290

1.36

1.02

5.5

6.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.18

0.98

1.0

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

190

1.43

0.97

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

191

1.42

0.95

1.8

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

303

1.33

0.94

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

183

1.43

0.94

1.2

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

158

1.46

0.94

3.4

3.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

134

1.50

0.92

1.2

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.67

0.91

1.8

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.67

0.91

1.2

2.1

—

(3037756) Immunofixation for Serum or Plasma

159

1.46

0.91

1.7

1.5

—

(3021901) Oxygen saturation in Capillary blood

126

1.52

0.91

3.6

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.75

0.90

2.9

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

377

1.28

0.89

1.8

—

(1002224) Polysomnography panel

485

1.25

0.89

1.2

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

120

1.51

0.85

2.5

3.2

0.8

1.3

0.49

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.88

0.82

1.3

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

1.55

0.81

1.3

1.6

—

(21494434) Karyotype in Bone marrow

1.61

0.81

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

172

1.40

0.81

3.6

3.3

58.3

56.9

0.28

172

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.73

0.79

1.7

2.4

—

(3045424) Erythrocytes [Presence] in Urine

165

1.40

0.78

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.52

0.75

1.2

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.52

0.75

1.2

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

150

1.41

0.73

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

100

1.51

0.73

1.2

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.00

0.72

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

110

0.54

0.72

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

101

1154

0.86

0.71

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

1.40

0.71

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

310

1.27

0.70

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.56

0.70

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.67

0.68

2.0

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.67

0.68

2.0

2.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

127

1.42

0.68

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

102

1.48

0.67

1.2

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

102

1.48

0.67

1.2

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.79

0.66

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.79

0.66

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

145

1.39

0.66

1.4

1.1

—

(40761536) Microorganisms panel - Urine sediment

838

0.85

0.65

3.9

3.3

—

(3017181) Myelocytes/100 leukocytes in Blood

767

1.16

0.64

3.6

4.2

1.0

0.04

195

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

711

1.16

0.64

3.9

3.3

mmol/l

1.2

0.46

612

(3006184) Hemoglobin [Mass/volume] in Capillary blood

172

1.34

0.64

3.7

2.2

g/l

128.1

130.9

0.18

135

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

172

1.34

0.64

1.2

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.73

0.64

1.8

1.5

ug/l

50.2

49.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

730

1.16

0.63

3.7

4.2

0.0

0.1

4.31

180

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

792

0.85

0.63

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

388

1.22

0.62

1.4

1.3

miu/ml

252.4

242.5

0.05

194

(3035933) Granulocytes/100 leukocytes in Blood

1.67

0.61

1.2

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

298

1.25

0.61

2.9

3.5

u/ml

55.3

1053.2

1.05

262

(44806071)

0.00

0.60

0.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

126

1132

1.13

0.60

1.7

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.57

0.58

11.5

7.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.51

0.58

2.5

3.0

u/ml

464.1

1166.7

—

(40767503) Oxygen content in Capillary blood by calculation

149

1.35

0.58

4.7

2.4

15.9

16.6

0.23

(3011648) Oxygen content in Venous blood

1.48

0.57

2.3

1.6

10.0

11.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.49

0.57

2.1

3.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

356

1.22

0.57

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

185

1.30

0.56

1.1

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

185

1.30

0.56

2.1

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

357

1.21

0.56

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

357

1.21

0.56

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

357

1.21

0.56

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.54

0.55

1.0

—

0.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

116

1.38

0.54

1.1

99.1

97.1

0.09

109

(3000093) Morphology [Interpretation] in Blood Narrative

1.48

0.53

1.1

—

(3025159) Blasts/100 leukocytes in Blood

695

1.15

0.53

3.8

4.3

0.0

1.2

0.96

153

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

226

0.75

0.52

1.3

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

152

1.32

0.52

1.2

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

1.45

0.52

2.8

3.4

mg/l

45.1

27.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.42

0.50

1.4

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

171

1.29

0.50

1.8

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

521

1.16

0.49

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

115

1263

0.90

0.48

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.42

0.47

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.42

0.47

1.2

1.3

u/ml

0.2

1.0

—

(1616796) Gas panel - Central venous blood

155

1.30

0.47

5.5

3.0

—

(3022313) Gas panel - Capillary blood

328

1.20

0.46

2.1

3.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

192

1.26

0.45

2.5

2.4

ug/min

20.2

74.4

1.66

124

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

202

1.24

0.43

3.9

2.9

u/ml

0.3

0.4

0.80

117

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

104

1.35

0.43

1.6

2.5

31.6

32.1

0.17

104

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

106

1160

0.91

0.42

5.1

4.0

31.4

32.8

0.75

801

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

149

1.28

0.42

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

6.4

—

0.3

—

(3004451) EKG impression Narrative

1.47

0.40

1.4

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.47

0.40

2.2

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

206

1.22

0.38

7.0

3.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

271

1.19

0.37

1.3

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

299

1.18

0.37

3.4

3.1

48.6

48.0

0.07

291

(3051387) C reactive protein [Mass/volume] in Capillary blood

224

0.80

0.37

4.0

3.7

mg/l

13.4

25.1

—

144

(3015183) Erythrocyte sedimentation rate

1.29

0.36

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.34

0.36

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

1.34

0.36

1.7

mosm/kgh2o

286.2

282.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.34

0.36

2.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

217

1.20

0.35

3.0

2.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

329

1.16

0.35

2.4

2.9

mmol/l

24.5

25.3

0.74

315

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

309

0.84

0.35

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

123

0.73

0.35

1.2

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

379

1.14

0.32

1.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

285

1.16

0.32

1.9

3.5

g/l

0.2

0.3

—

121

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.28

0.32

1.0

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

714

1.10

0.32

3.7

4.0

0.3

0.6

1.16

146

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

119

1.26

0.32

2.6

2.0

u/ml

6.6

38.3

0.48

114

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

101

1.29

0.31

1.2

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

305

1.15

0.31

1.8

1.7

—

(3042631) Mycobacterium sp identified in Specimen

100

0.70

0.30

1.9

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

431

1.12

0.28

1.3

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

119

0.75

0.27

1.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.68

0.26

1.0

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.68

0.26

1.0

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.68

0.26

1.0

1.7

—

(40768441) Liver Pathology biopsy report

1.25

0.25

1.6

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.23

0.25

2.0

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

340

1.12

0.24

1.8

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

0.81

0.24

1.5

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.32

0.23

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

295

1.12

0.22

2.1

2.2

iu/l

2.9

5.0

1.69

115

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.21

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

79.8

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

6.9

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

2.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

4.6

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

4.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.21

0.0

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.21

0.0

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

316

1.11

0.20

2.2

1.9

90.4

91.7

0.11

289

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.4

—

(40757373) Influenza virus identified in Isolate

0.00

0.20

0.0

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.25

0.20

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.25

0.20

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.13

0.18

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.13

0.18

1.0

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1.21

0.18

1.6

2.5

e9/l

0.2

—

(4306422)

166

1.15

0.18

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.13

0.17

1.7

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.22

0.17

1.0

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

167

1.14

0.17

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.72

0.17

1.2

1.4

—

(3044927) Protein electrophoresis panel - Urine

1.16

0.16

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

196

1.12

0.16

1.1

1.4

u/l

19.7

26.3

0.53

163

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

111

1.17

0.15

1.2

1.5

—

(3017732) Neutrophils [#/volume] in Blood

683

1.06

0.15

3.0

2.5

e9/l

3.7

4.0

0.65

568

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

645

1.06

0.14

1.5

—

(4281824)

139

0.86

0.14

1.1

1.2

—

(4035726)

911

1.05

0.14

1.3

1.4

—

(3019225) pH of Specimen

854

1.05

0.13

3.4

3.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

0.87

0.12

1.3

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

147

0.88

0.11

1.2

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

465

0.94

0.11

1.6

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

145

1.10

0.09

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

1.09

0.09

1.8

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.09

0.09

1.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.83

0.08

2.4

1.8

ug/l

14.1

24.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.79

0.08

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.09

0.08

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

1.14

0.08

2.7

3.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

205

0.93

0.08

1.3

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.03

0.08

1.4

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.03

0.08

1.1

1.5

—

(40768806) Pleura Pathology biopsy report

0.86

0.07

2.0

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.81

0.07

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.81

0.07

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

0.86

0.07

1.1

2.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

265

1.06

0.07

1.6

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.02

0.07

1.9

2.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.02

0.07

1.9

1.4

—

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.12

0.07

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.89

0.06

1.4

1.5

—

(44790047)

1.11

0.06

1.5

1.4

—

(44806118)

1.11

0.06

1.5

1.4

—

(44790048)

1.11

0.06

1.5

1.4

—

(44790049)

1.11

0.06

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

0.90

0.06

1.3

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

119

1.09

0.06

1.2

1.3

—

(40768793) Breast Pathology biopsy report

317

1.04

0.05

1.3

—

(4024509)

1.10

0.04

1.2

1.5

—

(40768800) Prostate Pathology biopsy report

1.10

0.04

1.2

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.10

0.04

1.0

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

219

0.96

0.03

1.7

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

798

1.02

0.03

1.9

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

480

1.02

0.02

1.6

mg/l

2.5

4.2

0.71

339

(3003694) ABO and Rh group [Type] in Blood

290

2888

1.01

0.01

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

116

0.95

0.00

3.0

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

164

1.04

0.00

1.1

128.4

116.5

1.15

152

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

126

1.03

0.00

2.5

2.6

—

(3012501) Base excess in Blood by calculation

174

0.98

0.00

6.0

2.7

mmol/l

2.6

2.8

0.08

121

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

201

0.99

0.00

1.3

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

878

1.00

0.00

3.0

2.8

—

(3045142) Bone marrow Pathology biopsy report

113

0.97

0.00

1.0

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

127

1.02

0.00

2.8

3.1

nmol/l

0.7

0.8

—

103

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

0.85

0.00

1.2

2.1

u/field

3.0

1.9

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.97

0.00

1.2

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

8.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.98

0.00

1.7

2.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3013762) Body weight Measured

0.00

0.0

1.7

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.00

0.00

1.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

1.00

0.00

1.1

mg/l

295.6

285.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

4.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.9

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

110

1.00

0.00

1.4

1.6

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

3.4

—

16.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

19.9

—

(3001729) Color of Synovial fluid

0.00

0.0

2.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.94

0.00

1.9

1.4

g/l

0.9

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

1.2

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.93

0.00

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012441) Differential panel - Pleural fluid

0.92

0.00

2.5

1.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

19.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.88

0.00

1.3

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SACROCOGG and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SACROCOGG	1.105 [0.97, 1.26]	0.129
Birth year	0.999 [0.99, 1.01]	0.725

During the follow-up period (1.1.1998 — 31.12.2019), 433 out of 4579 females with M13_SACROCOGG died.

Males

Parameter	HR [95% CI]	p-value
M13_SACROCOGG	1.055 [0.89, 1.25]	0.53
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 222 out of 1642 males with M13_SACROCOGG died.

Mortality risk

Mortality risk for people of age

years, who have M13_SACROCOGG.

N-year risk	Females	Males
1	0.171%	0.205%
5	0.745%	1.24%
10	1.591%	3.116%
15	3.086%	5.96%
20	5.65%	9.9%

Relationships between endpoints

↥

Index endpoint: M13_SACROCOGG – Sacrococcygeal disorders, not elsewhere classified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sacrococcygeal disorders, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints